Clarification of anastrozole/megestrol acetate trial program design.
Howell
A
A
D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D019290:Megestrol Acetate / Q000627:therapeutic use*; D009570:Nitriles / Q000627:therapeutic use*; D011446:Prospective Studies; D012107:Research Design; D014230:Triazoles / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D004791:Enzyme Inhibitors; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole; D019290:Megestrol Acetate